| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 05/09/2002 | US20020055667 Absorbable brachytherapy and chemotherapy delivery devices and methods |
| 05/09/2002 | US20020055666 Compositions and methods for treating disease utilizing a combination of radioactive therapy and cell-cycle inhibitors |
| 05/09/2002 | US20020055521 Analogs of cocaine |
| 05/09/2002 | US20020055464 Polyacid glycopeptide derivatives |
| 05/09/2002 | US20020054855 Gastrin receptor-avid peptide conjugates |
| 05/09/2002 | US20020054853 Rhenium and technetium complexes containing a hypoxia-localizing moiety |
| 05/09/2002 | US20020054851 32P-Polyphosphazenes |
| 05/08/2002 | EP1203020A1 Modulation of human sodium channels in dorsal root ganglia |
| 05/08/2002 | EP1203008A1 Nucleic acid ligands to cd40ligand |
| 05/08/2002 | EP1202973A1 Preparation of compounds useful for the detection of hypoxia |
| 05/08/2002 | EP1202945A1 Methods for preparing perfluorinated [18 f]-radiolabelled nitroimidazole derivatives for cellular hypoxia detection |
| 05/08/2002 | EP0789783B1 Antigen binding peptides (abtides) from peptide libraries |
| 05/08/2002 | CN1348449A Heteroaryl diazacycloalkanes, their preparation and use |
| 05/08/2002 | CN1348362A Magnetically responsive composition |
| 05/08/2002 | CN1084209C High polymer antineoplastic guide medicine and preparation thereof |
| 05/07/2002 | US6383217 Metal stent containing radioactivatable isotope and method of making same |
| 05/07/2002 | CA1341357C Platelet-specific chimeric immunoglobulin |
| 05/02/2002 | WO2002034300A1 Polymer based radionuclide containing particulate material |
| 05/02/2002 | WO2002034299A1 Inorganic low density radionuclide coated particles |
| 05/02/2002 | WO2002034298A1 Low density radionuclide-containing particulate material |
| 05/02/2002 | WO2002034249A1 Treatment of pcp addiction and pcp addiction-related behavior |
| 05/02/2002 | WO2001089584A3 Contrast agents |
| 05/02/2002 | WO2001068708A3 Human and humanized fap-alpha-specific antibodies |
| 05/02/2002 | WO2001054764A3 Bioabsorbable brachytherapy device |
| 05/02/2002 | US20020052594 Method and kit for imaging and treating organs and tissues |
| 05/02/2002 | US20020052481 Non-peptidyl moiety-conjugated CD4-gamma2 and CD4 -IgG2 immunoconjugates, and uses thereof |
| 05/02/2002 | US20020052357 Cyclic oxyguanidine pyrazinones as protease inhibitors |
| 05/02/2002 | US20020051990 Novel gene targets and ligands that bind thereto for treatment and diagnosis of ovarian carcinomas |
| 05/02/2002 | US20020051751 Therapy using the Mossbauer absorption phenomenon; pharmaceuticals containing radiation absorber isotope are administered and then excited; results in radiolysis of DNA resulting in lethal breaks in DNA molecules of target tissue |
| 05/02/2002 | EP1200451A1 Radiolabelled bisphosphonates and method |
| 05/02/2002 | EP1173192A4 Methods and compositions for targeted drug delivery |
| 05/02/2002 | EP1021205A4 Synthesis of ferrocenyl phenyltropane analogs and their radio-transformation to technetium neuroprobes for mapping monoamine reuptake sites |
| 05/02/2002 | EP1019102B1 32 p - polyphosphazene - radiolabelled antithrombogenic polymer |
| 05/02/2002 | CA2426602A1 Polymer based radionuclide containing particulate material |
| 05/01/2002 | CN1083714C Microcapsule contg. chemotherapeutic medicine and capsule-forming method |
| 04/30/2002 | US6379650 Technetium 99m-N2S2-congo red complexes utilizing diamide dithiolate ligand systems for radioimaging |
| 04/30/2002 | US6379649 Useful for diagnosis and treatment, including radiotherapy, of disorders that are characterized by an abnormal density of peripheral benzodiazepine receptors; nerve system disporders |
| 04/30/2002 | US6379648 Biodegradable glass compositions and methods for radiation therapy |
| 04/30/2002 | US6379647 Use of mononuclear phagocytes in in vivo imaging of hypoxic/ischaemic tissue |
| 04/30/2002 | US6379380 Metal stent containing radioactivatable isotope and method of making same |
| 04/30/2002 | CA2020247C Antibodies reactive with human carcinomas |
| 04/25/2002 | WO2002033116A2 Nucleic acid ligands to the prostate specific membrane antigen |
| 04/25/2002 | WO2002032294A2 Radiopharmaceutical formulations |
| 04/25/2002 | US20020049156 Polyhudroxy glycopeptide derivatives |
| 04/25/2002 | US20020048777 Nucleotide sequences for use in therapy, monitoring and screning preferential tumors |
| 04/25/2002 | US20020048598 Branched polymeric structure which provides a structural support for a mono-layer, bi-layer or multi-layered lipid coating. |
| 04/25/2002 | US20020048550 Radiolabeled immunotoxins |
| 04/25/2002 | US20020048549 Radioactive transition metal nitride heterocomplex |
| 04/25/2002 | CA2425605A1 Nucleic acid ligands to the prostate specific membrane antigen |
| 04/24/2002 | EP1198256A1 Peptide-lipid conjugates, liposomes and liposomal drug delivery |
| 04/24/2002 | EP1198254A2 Carrier-drug conjugate |
| 04/24/2002 | EP1198253A2 Biologically active materials |
| 04/24/2002 | EP0785951B1 Tc or re radiolabelled somatostatin analogs |
| 04/23/2002 | US6376654 Myeloma cell and ovarian cancer cell surface glycoproteins, antibodies thereto, and uses thereof |
| 04/23/2002 | US6376534 Guanidine compound; side effect reduction |
| 04/23/2002 | US6375927 Methods of radiotherapy using biomodulators |
| 04/23/2002 | US6375926 Human leucocyte elastase (hle) inhibitor labelled with a detectable moiety where the inhibitor is synthetic and the detectable moiety is chosen from a radioactive isotope, a paramagnetic ion, a radiopaque compound and an ultrasound |
| 04/23/2002 | US6375925 Administering labeled monoclonal antibody that binds oxidized low density lipoproteins; reducing residual radioactivity by by binding with antigen; evaluation; reduced backgground interference |
| 04/18/2002 | WO2002030984A1 Human anti-epidermal growth factor receptor single-chain antibodies |
| 04/18/2002 | WO2002030474A1 Kit for intraperitoneal administration and extracorpeal removal of a drug |
| 04/18/2002 | WO2002030473A1 Targeted therapeutic agents |
| 04/18/2002 | US20020045618 Heteroaryl diazacycloalkanes, their preparation and use |
| 04/18/2002 | CA2425508A1 Targeted therapeutic agents |
| 04/18/2002 | CA2422881A1 Human anti-epidermal growth factor receptor single-chain antibodies |
| 04/17/2002 | EP1197227A1 Method of the administration of drugs having binding affinity with plasma protein and preparation to be used in the method |
| 04/17/2002 | EP1196427A2 Novel c-19-halogen-substituted steroids of the androst-9(11)-ene-series, methods for the production and use thereof |
| 04/17/2002 | EP1196200A2 A radiolabeled mammalian tachykinin peptide analogue |
| 04/17/2002 | EP1196154A2 Inhibition of renal uptake of radiomolecules with a combination of lysine and arginine |
| 04/17/2002 | EP1196083A1 Imaging the dopamine transporter to determine ad-hd |
| 04/17/2002 | EP0839059B1 Cardiotropic radiopharmaceuticals comprising a transition metal nitride complex and having rapid myocardial clearance |
| 04/17/2002 | EP0734385B1 Substituted 2-carboxyalkyl-3-(fluorophenyl)-8-(3-halopropen-2-yl) nortropanes and their use as imaging agents for neurodegenerative disorders |
| 04/17/2002 | CN1345331A Method and composition for angiogenesis inhibition |
| 04/17/2002 | CN1345249A Kit for radiolabeling proteins with yttrium-90 |
| 04/16/2002 | US6373068 Apparatus and method for preparing radioactive medicines for administration |
| 04/16/2002 | CA2103556C Bicyclopolyazamacrocyclophosphonic acids, their complexes and conjugates, for use as contrast agents, and processes for their preparation |
| 04/11/2002 | WO2001098328A3 Glycopeptide phosphonate derivatives |
| 04/11/2002 | WO2001072780A3 Polynucleotides for diagnosing mammary gland cancer |
| 04/11/2002 | WO2000057923A9 Radioactive seed with multiple markers and method for using same |
| 04/11/2002 | WO2000012493A9 Thiazoline acid derivatives |
| 04/11/2002 | US20020042416 6-azauracil derivatives as IL-5 inhibitors |
| 04/11/2002 | US20020042394 Antibiotic, images for diagnosis |
| 04/11/2002 | US20020042387 Administering nucleic acid as antiinflammatory agent |
| 04/11/2002 | US20020042368 Integrin antagonists |
| 04/11/2002 | US20020042361 Use of a NK-1 receptor antagonist and an antidepressant and/or an anti-anxiety agent |
| 04/11/2002 | US20020042143 13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic control |
| 04/11/2002 | US20020042088 Method of diagnosing, monitoring, staging, imaging and treating gastrointestinal cancer |
| 04/11/2002 | US20020041878 Monitoring angiogenesis factor |
| 04/11/2002 | US20020041846 Metal complexes for use in medical and therapeutic applications |
| 04/10/2002 | EP1195168A2 Ternary radiopharmaceutical complexes |
| 04/10/2002 | EP1194557A2 An interleukin-1 receptor antagonist and uses thereof |
| 04/10/2002 | EP1194444A2 Labeled neurotensin derivatives with improved resistance to enzymatic degradation |
| 04/10/2002 | EP1194440A2 Induction of pharmacological stress with adenosine receptor agonists |
| 04/10/2002 | EP1194174A2 Extending the lifetime of anticoagulant oligodeoxynucleotide aptamers in blood |
| 04/10/2002 | EP1194173A1 X-ray guided drug delivery |
| 04/10/2002 | EP1194167A1 Immunotherapy of autoimmune disorders using antibodies which target b-cells |
| 04/10/2002 | CN2484953Y Medical radiative nucleary generator with concentrator |
| 04/10/2002 | CN1344276A Antibodies and FV fragment recognizing antigen IORC2 |
| 04/10/2002 | CN1344262A Perfuoroalkylamide, prodn. thereof and use thereof in diagnostics |
| 04/10/2002 | CN1343522A Radioactive macroaggregate and its prepn. method |
| 04/10/2002 | CN1343521A Preparing box for polysaccharide compounding substance |